Placental infection with Chlamydia pneumoniae and intrauterine growth restriction.
BACKGROUND
The concept that low birth weight infants are more predisposed to coronary artery disease (CAD) in adulthood has been studied extensively. Although many infectious agents have been associated with intrauterine growth restriction (IUGR), Chlamydia pneumoniae an organism implicated in CAD has not been investigated. It was our aim to assess whether C. pneumoniae DNA is present in placental tissue and whether its detection is associated with IUGR.


METHODS
Fifty-nine pregnant women were studied: 32 women had an uncomplicated pregnancy with no antenatal or post-natal evidence of IUGR. Twenty-seven women had pregnancies with ultrasonographically demonstrated IUGR, defined as foetal abdominal circumference measuring less than 2 S.D.s from the mean for gestational age. At the time of delivery, maternal blood and placental tissue samples were obtained. Placental samples were taken from four sites centrally and peripherally on the maternal and foetal side of the placentas and tested by nested polymerase chain reaction for C. pneumoniae DNA. IgG antibodies to C. pneumoniae were measured using microimmunfluorescence.


RESULTS
C. pneumoniae DNA was detected in 44% of the placental tissue but there was no difference in the prevalence of bacterial DNA between the control and the low birth weight group (P=0.58). Additionally C. pneumoniae seropositivity did not differ between the index and control groups (78 vs. 70%, P=0.44).


CONCLUSIONS
C. pneumoniae is present in placental tissue. Its presence however does not correlate with IUGR. Similarly, maternal C. pneumoniae seropositivity is not related to low birth weight. Thus C. pneumoniae infection is unlikely to play a role in the pathogenesis of IUGR.
Baboonian
Christina
C
Department of Cardiological Sciences, St. George's Hospital Medical School, Cranmer Terrace, London, SW17 0RE, UK.
Smith
David A
DA
Shapland
David
D
Arno
Gavin
G
Zal
Behnam
B
Akiyu
Julius
J
Kaski
Juan Carlos
JC
D000328:Adult; D000907:Antibodies, Bacterial / Q000032:analysis / Q000097:blood; D016022:Case-Control Studies; D002690:Chlamydia Infections / Q000150:complications* / Q000175:diagnosis; D016993:Chlamydophila pneumoniae; D004269:DNA, Bacterial / Q000032:analysis; D005260:Female; D005317:Fetal Growth Retardation / Q000000981:diagnostic imaging / Q000382:microbiology*; D006801:Humans; D007074:Immunoglobulin G / Q000032:analysis; D007150:Immunohistochemistry / Q000379:methods; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D010922:Placenta Diseases / Q000382:microbiology*; D016133:Polymerase Chain Reaction / Q000379:methods; D011247:Pregnancy; D016216:Ultrasonography, Prenatal
D000907:Antibodies, Bacterial; D004269:DNA, Bacterial; D007074:Immunoglobulin G